CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research

Positive
AI Analysis

Summary

START Center for Cancer Research appoints Dr. Salwan Al Mutar as Director of Clinical Research in Dallas-Fort Worth to expand access to innovative therapies. The appointment leverages his expertise in gastrointestinal oncology and early-phase clinical trials.

Importance:2/10
Sentiment:
0.30
LeadershipClinical ResearchGastrointestinal OncologyEarly-phase trialsTexas
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on April 9, 2026 12:01 PM

Read Original